GeneMetrics has unveiled a fully customizable genomics platform designed to address significant fragmentation in the health testing industry, where practitioners and companies have traditionally been forced to choose between consumer-friendly but superficial options or clinically robust but inflexible systems. The platform represents a departure from standard white-label solutions by offering complete customization across every aspect of testing, from kit design and sequencing technologies to report formats and recommendation engines.
The genetics marketplace currently suffers from disjointed solutions that negatively impact both providers and patients. Consumer-oriented kits often lack clinical depth, while specialized clinical platforms can be overly technical and rigid. This fragmentation forces practitioners to assemble incomplete solutions from multiple providers, leading to confusing patient experiences with multiple portals, contradictory interpretations, and overwhelming data formats. GeneMetrics addresses this by unifying lifestyle, clinical, diagnostic, and advanced genetic testing within a single platform where clients can combine genetics, bloodwork, and lifestyle factors into cohesive, actionable patient reports.
Unlike traditional private-label services that merely rebrand existing products, GeneMetrics functions as a custom testing product development company. Clients maintain complete control over sequencing options, report design, recommendation logic, and software integrations, allowing alignment with specific clinical philosophies and brand identities. The platform offers one of the industry's most extensive selections of sequencing technologies, including bead-chip genotyping arrays, clinical-grade Whole Exome Sequencing, clinical-grade Whole Genome Sequencing, PCR and PGx panels, and testing for epigenetics, blood, urine, saliva, and microbiomes.
GeneMetrics emphasizes actionable recommendations through a fully customizable engine that prioritizes supplements, diet, lifestyle modifications, or medications based on practitioner preferences. The company's scientific approach references over 140,000 peer-reviewed studies and maintains full auditability through a dedicated auditing system available at https://trust.genemetrics.com. Data security adheres to HIPAA, GDPR, SOC 2 Type 2, and ISO27001 standards with multi-layer encryption, and clients maintain 100 percent ownership of their data.
Early adopters have demonstrated significant impacts, including a U.S. functional medicine practice reducing practitioner analysis time by 70 percent, a European health AI firm scaling from 500 to 50,000 users in six months, and a Canadian wellness company tripling repeat kit orders after consolidating fragmented tests. The platform's scalability supports operations from boutique clinics to large genomics initiatives with unit costs potentially starting below $100. GeneMetrics operates exclusively as a backend provider without consumer-facing competition, offering what the company describes as "confidentiality as a service" to empower client innovation.
